Patent · US Active

Acute treatment and rapid treatment of headache using anti-CGRP antibodies

US12391749B2 · kind B2 · utility

0Cited by
40References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 23, 2023
Grant dateAug 19, 2025
Priority date
Expiry dateFeb 23, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.